Vitamin B6 and Magnesium- A Clinical Trial on ASD Patients
- Conditions
- Autism Spectrum Disorder
- Registration Number
- NCT03963479
- Lead Sponsor
- Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- Brief Summary
To determine whether Vitamin B6 and Magnesium improve neurobehavioral status in terms of General observation, Cognitive working, Socialization, Communication and Sensory Dysfunction in patient with Autism Spectrum Disorder.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 50
- Children between 2 to 12 years of age suspected ASD assessed by DSM-5 and ADCL tool
- Each patient will be free of psychoactive medication for atleast 3 months prior to the entry into the trial
- Newly diagnosed patient
- Co-morbid neurological disorder like hyperactivity
- Patients with chronic diseases or any known metabolic or hormonal diseases
- Patients with any known chromosomal or genetic syndromes
- Patients unable to give informed consent
- Patients unable to travel to clinical visits or non co-operative
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Autism Spectrum Disorder 3 months General observation, Cognitive Working, socialization, Communication, Sensory Dysfunction.
At first a autism will be diagnosed by DSM-5 .Then the above mention criterias along with the severity will be diagnosed by Autism Diagnostic Checklist tool by a psychologist.
- Secondary Outcome Measures
Name Time Method Autism Spectrum Disorder 0 month The Autism Diagnostic Checklist will be repeated to compare the outcomes in terms of General observation, Cognitive Working, socialization, Communication, Sensory along with the severity of the Autism.
Trial Locations
- Locations (1)
Farhana Khan
🇧🇩Dhaka, Bangladesh
Farhana Khan🇧🇩Dhaka, BangladeshMd. Sayedur Rahman, MBBS, MPhilContact8801971840757srkhasru@gmail.com